Jeffrey Engelmann

Dr. Jeffrey Engelmann

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2011 in Psychophysiology
Verified
Journal Article
Open access
PDF file
JEJeffrey Engelmann
Jeffrey Engelmann
JGJonathan C. Gewirtz
Jonathan C. Gewirtz
BCBruce N. Cuthbert
Bruce N. Cuthbert
Negative affect is thought to be an important factor in the maintenance of cigarette smoking, and thus it is important to further develop objective measures of smoking‐related emotional responses. Nonsmokers, nonabstinent smokers, and abstinent smokers participated in a cue reactivity task where eyeblink startle amplitude and startle probe P300 (P3) suppression were measured during the presentation of emotional pictures. During unpleasant pictures, the amplitude of both measures was smaller in nonabstinent smokers than in nonsmokers or abstinent smokers. P3 suppression, but not startle amplitude, was larger in abstinent smokers than in nonsmokers. Abstinence‐induced increases in cigarette craving were associated with P3 suppression during tobacco‐related pictures. Results suggest that tobacco abstinence increases emotional reactivity to unpleasant stimuli, which is consistent with negative reinforcement models of tobacco addiction.

1 November 2022 in Psychology of Addictive Behaviors
Verified
Journal Article
Closed access
JRJason D Robinson
Jason D Robinson
YCYong Cui
Yong Cui
PAPaulina Linares Abrego
Paulina Linares Abrego
JEJeffrey Engelmann
Jeffrey Engelmann
APAlexander V. Prokhorov
Alexander V. Prokhorov
PCPaul M. Cinciripini
Paul M. Cinciripini
Cigarette smoking is thought to be at least partially maintained by the attentional bias (AB) toward smoking cues that develops as a consequence of drug dependence. This study evaluated the impact of smartphone-delivered, in-home attentional bias modification (ABM) to reduce AB to smoking cues and to reduce smoking behavior and withdrawal-related symptoms when used as an adjunct to conventional smoking cessation treatment. Participants (N = 246) were treatment-seeking smokers who completed up to 13 days of either ABM designed to train attention away from smoking cues, using a modified dot-probe task, or sham training, followed by 8 weeks of nicotine replacement therapy and counseling. Outcomes measured at baseline, 1-day post-ABM training, and 8 weeks post-ABM training included AB to smoking images and words using the dot-probe and smoking Stroop tasks, respectively, along with cigarettes per day, craving, and smoking abstinence. We found that ABM training reduced AB to smoking stimuli on both the dot-probe task, ηp² = 0.056, 90% CI [0.024, 0.097], and the smoking Stroop task, ηp² = 0.017, 90% CI [0.002, 0.044], up to 8 weeks after ABM training when covarying for baseline response, but did not concurrently decrease smoking behavior or craving. Thirteen days of smartphone-delivered ABM training, as an adjunct to smoking cessation treatment, reduced AB to both modality-specific and cross-modality smoking cues but did not impact smoking-related behavior. While ABM can reduce AB to smoking cues across modalities, it is unclear whether it has therapeutic potential as an adjunct to conventional smoking cessation therapy. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

4 October 2023 in JAACAP Open
Verified
Journal Article
Open access
MFMartin Edward Franklin
Martin Edward Franklin
JEJeffrey Engelmann
Jeffrey Engelmann
NBNyssa Z. Bulkes
Nyssa Z. Bulkes
GHGregor Horvath
Gregor Horvath
KPKelly Piacsek
Kelly Piacsek
BRBradley C. Riemann
Bradley C. Riemann
This naturalistic, nonblinded, nonrandomized study examined the efficacy of multimodal treatment including intensive cognitive-behavioral therapy (CBT) for pediatric obsessive-compulsive disorder (OCD) delivered via telehealth (TH) compared with a matched sample of youth treated in person (IP). Patients included 1,286 youth ages 7 to 17 inclusive (643 TH, 643 IP) who received TH or IP in either partial hospitalization (n = 818) or intensive outpatient (n = 468) programs. Changes in patient-rated OCD symptoms and quality of life from pretreatment to posttreatment were examined. TH patients were discharged with a statistically higher Children’s Yale-Brown Obsessive-Compulsive Scale Self-Report score than IP patients, although this group difference (1.4) was not clinically significant. Quality-of-life scores at discharge did not significantly differ between TH patients and IP patients. Treatment response was robust attesting to the broad applicability of the treatment model. Youth receiving CBT via TH responded both well and comparably to youth treated IP, offering a viable access path forward. These findings extend the reach of CBT for pediatric OCD. Concerted efforts must now be made to improve CBT availability for families for whom financial, insurance, geographical, and other barriers preclude access at present. We worked to ensure that the study questionnaires were prepared in an inclusive way. We worked to ensure sex and gender balance in the recruitment of human participants. We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. We actively worked to promote sex and gender balance in our author group. While citing references scientifically relevant for this work, we also actively worked to promote sex and gender balance in our reference list. While citing references scientifically relevant for this work, we also actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our reference list.

9 May 2026 in Children
Verified
Journal Article
Open access
PDF file
SYSarah Yale
Sarah Yale
JEJeffrey Engelmann
Jeffrey Engelmann
MLMichelle Loman
Michelle Loman
DSDaJhnae Gambrell Sanders
DaJhnae Gambrell Sanders
MMMohit Maheshwari
Mohit Maheshwari
TMTheresa Mikhailov
Theresa Mikhailov
Introduction: Electronic nicotine delivery systems (ENDSs), also known as e-cigarettes or vapes, have shown popularity among the adolescent population. Compared to adults, less is known regarding the impacts of ENDS and nicotine on the adolescent brain. Adolescent research related to nicotine and other illicit substances can be difficult due to the requirement of parent/guardian consent, adolescent hesitancy for disclosure of product use, and the continually evolving vaping and nicotine products on the market. Despite these challenges, further research is needed to explore the impact of ENDS on the developing adolescent brain. The objective of the study was to evaluate reward sensitivity and cognitive flexibility in the adolescent population using functional magnetic resonance imaging (fMRI) through a probabilistic reversal learning task. Methods: This pilot study recruited participants aged 13–19 years old to complete fMRI testing. We specifically adapted a probabilistic reversal learning task that was previously used to measure reward sensitivity and cognitive flexibility in adults (including nicotine users). We were unable to recruit enough ENDS users to complete the planned analysis; therefore, we evaluated non-users as proof of concept for the use of the probabilistic reversal learning task in adolescents to support future research. Participants completed four blocks of a probabilistic reversal learning task, each lasting 6 min. During each block of the task, blood-oxygenation-level-dependent (BOLD) fMRI images were collected. The reward sensitivity and cognitive flexibility contrasts of parameter estimates were entered into a group analysis model. Due to the small sample size and exploratory nature of the study, we were interested in computing population-level estimates of brain activation that could be attributed to reward sensitivity (win-stay minus lose-stay trials) and cognitive flexibility (lose-shift trials minus lose-stay trials). Results: A total of twelve participants completed fMRI testing—ten non-users, one intermittent user, one regular user. Four of these participants (three non-users and one intermittent user) were excluded from the fMRI analysis due to excessive head movement and/or poor task performance. With the seven remaining non-users, we found no evidence of significant BOLD activation when strictly controlling the Type I error rate. Using a more liberal statistical threshold that did not control the Type I error rate, both contrasts resulted in suprathreshold clusters in occipital and posterior parietal regions, and the reward sensitivity contrast also resulted in suprathreshold clusters in the prefrontal cortex (bilateral middle occipital gyrus). Discussion/Conclusions: We did not find statistically significant BOLD activation, which is likely due to the small sample size. Suprathreshold clusters using the liberal statistical threshold may be feasible for use as regions of interest in future studies using this task. Notably, the prefrontal regions where the reward sensitivity contrast exceeded the liberal statistical threshold in our study were similar to those observed in previous studies of reward sensitivity in adults (including nicotine users) and adolescents. This pilot study explores the use of an fMRI reward-learning paradigm in the adolescent population, which can serve as a catalyst for future research related to nicotine use.

6 January 2025 in Research Square
Verified
Preprint
Open access
PDF file
SGSheldon R. Garrison
Sheldon R. Garrison
SSSophie A. Schweinert
Sophie A. Schweinert
MBMatthew W. Boyer
Matthew W. Boyer
MSMaharaj Singh
Maharaj Singh
SVSreya Vadapalli
Sreya Vadapalli
MHMadeline M. Hartig
Madeline M. Hartig
Purpose This study evaluated pharmacogenomic (PGx) testing in children and adolescents with autism spectrum disorder (ASD). ASD frequently presents with co-occurring depression and anxiety. This complex phenotype often results in psychotropic medication polypharmacy. Incorporating PGx testing into the medical work-up may reduce polypharmacy and improve quality of life with symptom reduction. Methods A retrospective electronic health record review between January 2017 to May 2023. Individuals either received PGx testing or treatment as usual (TAU). The co-primary outcomes were polypharmacy and the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q). Secondary outcomes included length of stay and assessments measuring severity or behavioral impact. Results A total of 99 individuals with ASD were analyzed. At the time of admission, 93% of individuals were prescribed at least one psychotropic medication and over half of these individuals were prescribed medications with potential gene-drug interactions. Following PGx testing, there was an overall reduction in prescribed medications with a potential gene-drug interaction. Quality of life and symptom assessments of depression, anxiety, obsessive-compulsive disorder and body-focused repetitive behaviors revealed similar improvements in the PGx and TAU groups. Subanalysis comparing congruent (“use as directed”) or incongruent (“use with caution”), as well as analysis of only CYP2D6 and CYP2C19 gene-drug interactions, were observed to have a similar profile. Conclusion Combinatorial PGx testing was utilized as a clinical decision-making tool for medication selection and dosage adjustment. As a result, all treatment groups were able to achieve similar levels of polypharmacy, improvement in quality of life and symptom reduction.

1 February 2023 in Journal of Medical Imaging
Verified
Journal Article
Closed access
PDF file
HWHaoqi Wang
Haoqi Wang
KNKrista Nicklaus
Krista Nicklaus
EJEloise Jewett
Eloise Jewett
EREeshaan Rehani
Eeshaan Rehani
TCTzuan Chen
Tzuan Chen
MMMia K. Markey
Mia K. Markey
PurposeSaliency models that predict observers’ visual attention to facial differences could enable psychosocial interventions to help patients and their families anticipate staring behaviors. The purpose of this study was to assess the ability of existing saliency models to predict observers’ visual attention to acquired facial differences arising from head and neck cancer and its treatment.ApproachSaliency maps predicted by graph-based visual saliency (GBVS), an artificial neural network (ANN), and a face-specific model were compared to observer fixation maps generated from eye-tracking of lay observers presented with clinical facial photographs of patients with a visible or functional impairment manifesting in the head and neck region. We used a linear mixed-effects model to investigate observer and stimulus factors associated with the saliency models’ accuracy.ResultsThe GBVS model predicted many irrelevant regions (e.g., shirt collars) as being salient. The ANN model underestimated observers’ attention to facial differences relative to the central region of the face. Compared with GBVS and ANN, the face-specific saliency model was more accurate on this task; however, the face-specific model underestimated the saliency of deviations from the typical structure of human faces. The linear mixed-effects model revealed that the location of the facial difference (midface versus periphery) was significantly associated with saliency model performance. Model performance was also significantly impacted by interobserver variability.ConclusionsExisting saliency models are not adequate for predicting observers’ visual attention to facial differences. Extensions of face-specific saliency models are needed to accurately predict the saliency of acquired facial differences arising from head and neck cancer and its treatment.